Total planned funding: $847,986,326
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $160,366,285 |
Kenya | $116,383,911 |
South Africa | $89,503,135 |
Tanzania | $88,220,347 |
Malawi | $59,611,518 |
Uganda | $55,530,114 |
Zambia | $55,408,400 |
Ethiopia | $42,013,934 |
Botswana | $28,385,082 |
Côte d'Ivoire | $26,387,683 |
Eswatini | $20,777,591 |
Democratic Republic of the Congo | $17,288,812 |
Lesotho | $15,379,918 |
Haiti | $13,860,500 |
Namibia | $11,196,097 |
South Sudan | $9,524,993 |
Rwanda | $9,009,465 |
Zimbabwe | $5,686,468 |
Nigeria | $4,191,848 |
Ukraine | $3,150,000 |
Vietnam | $3,086,851 |
Angola | $2,450,000 |
Central Asia Region | $2,374,000 |
Caribbean Region | $2,217,812 |
Cameroon | $1,750,000 |
Burundi | $1,100,000 |
Ghana | $950,000 |
Guyana | $816,562 |
India | $750,000 |
Dominican Republic | $565,000 |
Asia Regional Program | $50,000 |
Central America Region | $0 |
Organizational Types
University | $847,986,326 |
Program Areas
Prevention | $271,435,111 |
Treatment | $257,416,641 |
Care | $133,285,364 |
Governance and Systems | $122,059,907 |
Testing | $63,639,303 |
Budget Codes
HTXS: Treatment: Adult Treatment | $222,543,859 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $138,470,464 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $66,598,755 |
HVCT: Testing: HIV Testing and Counseling | $63,639,303 |
OHSS: Health Systems Strengthening | $56,663,689 |
HVSI: Strategic Information | $50,545,411 |
HBHC: Care: Adult Care and Support | $49,533,317 |
HVOP: Sexual Prevention: Other Sexual Prevention | $48,491,755 |
HVTB: Care: TB/HIV | $36,868,940 |
PDTX: Treatment: Pediatric Treatment | $34,772,782 |
HKID: Care: Orphans and Vulnerable Children | $25,082,009 |
PDCS: Care: Pediatric Care and Support | $21,801,098 |
HLAB: Laboratory Infrastructure | $14,850,807 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,127,622 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,786,195 |
HMIN: Biomedical Prevention: Injection Safety | $2,882,160 |
HMBL: Biomedical Prevention: Blood Safety | $1,078,160 |
HTXD: Treatment: ARV Drugs | $100,000 |
Top Partner Programs
Johns Hopkins University:
$250,549,261
View countries
Baylor College of Medicine:
$46,921,454
View countries